A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
about
Special Technologies for Ex Vivo Analysis of CancerInhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumoursAntineoplastic effect of decoy oligonucleotide derived from MGMT enhancer.Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapyThe promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysisLive and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotectionThe therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitors.Resistance to chemotherapy in cancer: a complex and integrated cellular response.Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy.
P2860
Q28087644-B7ED9A91-265D-4F4F-903F-14D711336FE1Q33396508-57364651-2186-47E3-B03F-EC9E956E1237Q34612054-90976CC7-4CD8-4C84-9E9F-4E9021915A62Q35194850-55E5B0FA-01A1-4C87-A2C4-E4F05393189FQ36012002-3A0F059E-9241-4B59-956C-97A6D6C633C9Q36225952-77AC3E41-2D50-4B17-AF2E-AC9CC8C5FE5FQ36459144-22D94CBA-1515-4887-BA22-24C19999D8C4Q36702401-34C0ADB6-3B24-48C3-AC32-C23566443E19Q36812597-B85AF837-E9C3-4D73-A5B4-6851DD312ADAQ36964700-B1807CCB-933B-4199-9079-3FCC910574BDQ37079652-92DE961D-E336-4765-9C72-F1A810C66F7EQ37121130-283E00C4-81FF-415F-A41A-E15DCA48FBB6Q37823790-6A7427A1-1C0A-4D6E-947D-E36574906BB8Q37888461-DFFF940F-4B12-40FA-9FE9-5B98E8ACE697Q48504707-6F56755E-5027-4508-8C88-991DF654C9FF
P2860
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@ast
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@en
type
label
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@ast
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@en
prefLabel
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@ast
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@en
P2093
P1476
A phase II trial of O6-benzylg ...... advanced soft tissue sarcoma.
@en
P2093
Brian L Samuels
Bruce B Brockstein
Christopher W Ryan
Edem S Agamah
M Eileen Dolan
Shannon M Delaney
P2888
P304
P356
10.1007/S00280-006-0210-0
P577
2006-03-07T00:00:00Z
P6179
1048902243